FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1891620937> ?p ?o ?g. }

• W1891620937 endingPage "2958" @default.
• W1891620937 startingPage "2953" @default.
• W1891620937 abstract "The effect of in vivo administration of murine recombinant gamma interferon (IFN) on the fungicidal activity of murine peripheral blood polymorphonuclear neutrophils (PB-PMNs) was studied. Mice were injected intramuscularly with 250, 2,500, 25,000 or 250,000 U of IFN 5 h before collection of peripheral blood. Purified PB-PMNs were cocultured in vitro with Blastomyces dermatitidis yeast cells for 2 h. PB-PMNs from untreated mice killed 44.5 +/- 12.5% of the fungal inoculum, whereas PB-PMNs from mice treated with 25,000 or 250,000 U of IFN showed significantly enhanced in vitro killing (68.0 +/- 9.4% [P less than 0.005] and 72.3 +/- 1.1% [P less than 0.001], respectively). Treatment with 250 or 2,500 U of IFN or 25,000 U of heated (100 degrees C, 15 min) IFN had no effect. The IFN-induced activation of PB-PMNs was transitory. Significant enhancement of PB-PMN killing activity occurred 1, 2, or 5 h after in vivo IFN administration, but no enhancement was observed 16 or 24 h after IFN treatment. Enhanced fungicidal activity by PB-PMNs from mice treated for 5 h with 25,000 U of IFN correlated with an increased release of superoxide anion (O2-) in vitro after stimulation of PB-PMNs with phorbol ester; normal PB-PMNs and IFN-activated PB-PMNs, respectively, produced 2.2 +/- 2.5 and 23.5 +/- 4.8 nmol of O2- per 10(6) PB-PMNs per 30 min (P less than 0.005). The exogenous addition of compounds that antagonize or inhibit the formation of oxygen radicals (superoxide dismutase, catalase, dimethyl sulfoxide, or sodium azide) significantly inhibited fungal killing by both normal and IFN-activated PB-PMNs. In addition to the enhanced microbicidal activity and superoxide generation demonstrated in vitro with constant cell numbers, there was a transient leukocytosis (particularly neutrophilia) in peripheral blood at doses of IFN and at times after IFN administration where enhanced activity was also demonstrated. In summary, our results indicate that PB-PMNs can be activated in vivo for enhanced killing of a fungal target. The enhanced killing capacity of IFN-activated PB-PMNs is due at least in part to the enhancement of oxidative killing mechanisms." @default.
• W1891620937 created "2016-06-24" @default.
• W1891620937 creator A5009082087 @default.
• W1891620937 creator A5021143803 @default.
• W1891620937 creator A5061462226 @default.
• W1891620937 date "1989-10-01" @default.
• W1891620937 modified "2023-09-24" @default.
• W1891620937 title "In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing" @default.
• W1891620937 cites W1816400361 @default.
• W1891620937 cites W1903498165 @default.
• W1891620937 cites W1912782953 @default.
• W1891620937 cites W1933109781 @default.
• W1891620937 cites W1947510494 @default.
• W1891620937 cites W1998047654 @default.
• W1891620937 cites W2021457622 @default.
• W1891620937 cites W2025748176 @default.
• W1891620937 cites W2048243713 @default.
• W1891620937 cites W2056234608 @default.
• W1891620937 cites W2059817483 @default.
• W1891620937 cites W2063148621 @default.
• W1891620937 cites W2071027974 @default.
• W1891620937 cites W2071107113 @default.
• W1891620937 cites W2092973954 @default.
• W1891620937 cites W2095998080 @default.
• W1891620937 cites W2106628062 @default.
• W1891620937 cites W2112458199 @default.
• W1891620937 cites W2116168633 @default.
• W1891620937 cites W2116520811 @default.
• W1891620937 cites W2134707295 @default.
• W1891620937 cites W2153741820 @default.
• W1891620937 cites W2165776283 @default.
• W1891620937 cites W2168891026 @default.
• W1891620937 cites W2174934515 @default.
• W1891620937 cites W2188007743 @default.
• W1891620937 cites W2314757575 @default.
• W1891620937 cites W2321769300 @default.
• W1891620937 cites W2325825676 @default.
• W1891620937 cites W2334923455 @default.
• W1891620937 cites W2398158424 @default.
• W1891620937 cites W2398662587 @default.
• W1891620937 cites W4230455701 @default.
• W1891620937 doi "https://doi.org/10.1128/iai.57.10.2953-2958.1989" @default.
• W1891620937 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/260754" @default.
• W1891620937 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2550367" @default.
• W1891620937 hasPublicationYear "1989" @default.
• W1891620937 type Work @default.
• W1891620937 sameAs 1891620937 @default.
• W1891620937 citedByCount "41" @default.
• W1891620937 countsByYear W18916209372015 @default.
• W1891620937 countsByYear W18916209372020 @default.
• W1891620937 countsByYear W18916209372021 @default.
• W1891620937 crossrefType "journal-article" @default.
• W1891620937 hasAuthorship W1891620937A5009082087 @default.
• W1891620937 hasAuthorship W1891620937A5021143803 @default.
• W1891620937 hasAuthorship W1891620937A5061462226 @default.
• W1891620937 hasBestOaLocation W18916209371 @default.
• W1891620937 hasConcept C134018914 @default.
• W1891620937 hasConcept C150903083 @default.
• W1891620937 hasConcept C153911025 @default.
• W1891620937 hasConcept C181199279 @default.
• W1891620937 hasConcept C198677920 @default.
• W1891620937 hasConcept C202751555 @default.
• W1891620937 hasConcept C203014093 @default.
• W1891620937 hasConcept C207001950 @default.
• W1891620937 hasConcept C24998067 @default.
• W1891620937 hasConcept C2776178377 @default.
• W1891620937 hasConcept C2777983669 @default.
• W1891620937 hasConcept C2780795997 @default.
• W1891620937 hasConcept C2780841837 @default.
• W1891620937 hasConcept C55493867 @default.
• W1891620937 hasConcept C86803240 @default.
• W1891620937 hasConcept C89423630 @default.
• W1891620937 hasConceptScore W1891620937C134018914 @default.
• W1891620937 hasConceptScore W1891620937C150903083 @default.
• W1891620937 hasConceptScore W1891620937C153911025 @default.
• W1891620937 hasConceptScore W1891620937C181199279 @default.
• W1891620937 hasConceptScore W1891620937C198677920 @default.
• W1891620937 hasConceptScore W1891620937C202751555 @default.
• W1891620937 hasConceptScore W1891620937C203014093 @default.
• W1891620937 hasConceptScore W1891620937C207001950 @default.
• W1891620937 hasConceptScore W1891620937C24998067 @default.
• W1891620937 hasConceptScore W1891620937C2776178377 @default.
• W1891620937 hasConceptScore W1891620937C2777983669 @default.
• W1891620937 hasConceptScore W1891620937C2780795997 @default.
• W1891620937 hasConceptScore W1891620937C2780841837 @default.
• W1891620937 hasConceptScore W1891620937C55493867 @default.
• W1891620937 hasConceptScore W1891620937C86803240 @default.
• W1891620937 hasConceptScore W1891620937C89423630 @default.
• W1891620937 hasIssue "10" @default.
• W1891620937 hasLocation W18916209371 @default.
• W1891620937 hasLocation W18916209372 @default.
• W1891620937 hasLocation W18916209373 @default.
• W1891620937 hasOpenAccess W1891620937 @default.
• W1891620937 hasPrimaryLocation W18916209371 @default.
• W1891620937 hasRelatedWork W1999407296 @default.
• W1891620937 hasRelatedWork W2031575817 @default.
• W1891620937 hasRelatedWork W2046533420 @default.
• W1891620937 hasRelatedWork W2053759669 @default.

• next